AMI Investment Management Inc. Has $2.45 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

AMI Investment Management Inc. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,945 shares of the healthcare conglomerate’s stock after buying an additional 40 shares during the quarter. AMI Investment Management Inc.’s holdings in UnitedHealth Group were worth $2,446,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC grew its position in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the last quarter. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $31,000. LFA Lugano Financial Advisors SA grew its position in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares in the last quarter. Finally, Transcendent Capital Group LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 4.7 %

Shares of NYSE:UNH opened at $509.26 on Monday. The firm has a market cap of $468.72 billion, a P/E ratio of 31.13, a P/E/G ratio of 1.48 and a beta of 0.60. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The business has a fifty day simple moving average of $498.34 and a 200 day simple moving average of $501.63.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period last year, the company earned $6.26 EPS. Analysts predict that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were issued a dividend of $2.10 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on UNH. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday. Royal Bank of Canada reduced their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Barclays upped their target price on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Finally, Robert W. Baird initiated coverage on UnitedHealth Group in a research note on Thursday, May 30th. They set an “outperform” rating and a $597.00 target price for the company. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.